At a glance
- Originator Medivir AB
- Developer Medivir AB; Nonindustrial source
- Class Antivirals; Nucleosides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 15 Feb 2001 No-Development-Reported for HIV infections treatment in Sweden (SC)
- 29 Aug 1997 New profile
- 19 Aug 1997 Preclinical development for HIV infections treatment in Sweden (SC)